
	Three Months Ended
	March 31, 2024		March 31, 2023
	(in thousands, except per share data)
Basic and Diluted Loss Per Share:
Net loss	$	(17,757)	$	(98,732)
Weighted-average common shares outstanding used to compute net loss per share	139,297		134,667



Basic and diluted loss per share	$	(0.13)	$	(0.73)

The following weighted-average shares have been excluded from the calculation of diluted net loss per share attributable to common stockholders for each period presented because they are anti-dilutive:


	Three Months Ended
	March 31, 2024	March 31, 2023
	(in thousands)
Unvested restricted stock units	2,558	1,738
Options to purchase common stock	1,572	1,742

Unvested performance stock units	241	135
ESPP shares	65	17
Convertible Senior Notes	3,210	6,026
Total shares excluded from net loss per share	7,646	9,658

For the three months ended March 31, 2024 and 2023, the Company excluded outstanding performance stock units from the calculation of diluted net loss per share because they were anti-dilutive. As of March 31, 2024, the performance stock units granted during 2021, 2022, 2023, and 2024 had expected achievement levels of 0%, 80%, 93%, and 150%, respectively. As of March 31, 2023, the performance stock units granted in 2020, 2021, 2022, and 2023 had expected achievement levels of 94%, 0%,

For the three months ended March 31, 2024 and 2023, shares that would be issuable assuming conversion of all of the Convertible Senior Notes (as defined in Note 13) were excluded from the calculation of diluted loss per share because they were anti-dilutive. The Convertible Senior Notes have an initial conversion rate of 15.6539 shares of common stock per $1,000 principal amount of the Convertible Senior Notes, which will be subject to anti-dilution adjustments in certain circumstances. As of March 31, 2024 and 2023, the number of shares that would be issuable assuming conversion of all of the Convertible Senior Notes is approximately 3,210,098 and 5,474,952, respectively.